Bay City Capital LLC insider trades: Xilio Therapeutics (XLO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bay City Capital LLC reports to the SEC
and 8 more companies
Open-market buys and sales
40 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | XLO | ↑ Buy | 312,500 | $16.00 | $5.0M | Indirect | Oct 26, 2021 (0d) |
| Aug 19, 2020 | MDGL | ↓ Sell | 30,000 | $109.74 | $3.3M | Direct | Aug 19, 2020 (0d) |
| Dec 13, 2019 | MDGL | ↓ Sell | 1,200,000 | $105.47 | $126.6M | Indirect | Dec 13, 2019 (0d) |
| Jun 25, 2018 | KZR | ↑ Buy | 150,000 | $15.00 | $2.3M | Indirect | Jun 28, 2018 (3d) |
| Jun 11, 2018 | MDGL | ↓ Sell | 280,000 | $287.46 | $80.5M | Indirect | Jun 12, 2018 (1d) |
| Jul 29, 2016 | ILIU | ↑ Buy | 30,181,086 | $0.10 | $3.0M | Indirect | Aug 2, 2016 (4d) |
| Jan 12, 2016 | EPZM | ↑ Buy | 555,555 | $9.00 | $5.0M | Indirect | Jan 12, 2016 (0d) |
| Jul 24, 2015 | SNSS | ↓ Sell | 635,702 | $3.46 | $2.2M | Indirect | Jul 28, 2015 (4d) |
| Jun 8, 2015 | NVRO | ↓ Sell | 491,835 | $47.94 | $23.6M | Direct | Jun 17, 2015 (9d) |
| Dec 23, 2014 | ILIU | ↑ Buy | 26,491,952 | $0.10 | $2.7M | Indirect | Dec 24, 2014 (1d) |
| Oct 8, 2014 | DERM | ↑ Buy | 69,112 | $16.00 | $1.1M | Indirect | Oct 8, 2014 (0d) |
| Aug 28, 2014 | SNSS | ↓ Sell | 300,700 | $7.98 | $2.4M | Direct | Aug 29, 2014 (1d) |
| Aug 26, 2014 | EPZM | ↓ Sell | 200,000 | $35.14 | $7.0M | Indirect | Aug 28, 2014 (2d) |
| Aug 25, 2014 | EPZM | ↓ Sell | 366,666 | $33.98 | $12.5M | Indirect | Aug 25, 2014 (0d) |
| Aug 12, 2014 | SNSS | ↓ Sell | 743,700 | $6.64 | $4.9M | Direct | Aug 12, 2014 (0d) |
| Feb 10, 2014 | EPZM | ↓ Sell | 466,667 | $29.25 | $13.7M | Indirect | Feb 12, 2014 (2d) |
| Jun 5, 2013 | EPZM | ↑ Buy | 166,666 | $15.00 | $2.5M | Indirect | Jun 7, 2013 (2d) |
| May 30, 2013 | HPTX | ↓ Sell | 17,366 | $21.06 | $366K | Direct | May 30, 2013 (0d) |
| May 20, 2013 | HPTX | ↓ Sell | 131,455 | $22.68 | $3.0M | Direct | May 21, 2013 (1d) |
| Sep 23, 2011 | ETRM | ↑ Buy | 840,000 | $1.65 | $1.4M | Direct | Sep 26, 2011 (3d) |
| Dec 14, 2010 | ETRM | ↑ Buy | 1,700,000 | $1.74 | $3.0M | Direct | Dec 16, 2010 (2d) |
| Jun 30, 2010 | SNSS | ↑ Buy | 23,824,450 | $0.28 | $6.6M | Direct | Jul 1, 2010 (1d) |
| Feb 19, 2009 | ETRM | ↑ Buy | 1,649,485 | $1.15 | $1.9M | Direct | Feb 20, 2009 (1d) |
| Oct 24, 2008 | ETRM | ↑ Buy | 49,600 | $1.10 | $55K | Direct | Oct 28, 2008 (4d) |
| Apr 29, 2008 | ETRM | ↑ Buy | 25,000 | $4.50 | $113K | Direct | Apr 30, 2008 (1d) |
| Apr 24, 2008 | ETRM | ↑ Buy | 50,000 | $4.50 | $225K | Direct | Apr 28, 2008 (4d) |
| Feb 29, 2008 | ETRM | ↑ Buy | 21,000 | $8.66 | $182K | Direct | Mar 4, 2008 (4d) |
| Nov 15, 2007 | ETRM | ↑ Buy | 375,000 | $8.00 | $3.0M | Direct | Nov 19, 2007 (4d) |
| Aug 30, 2007 | PARD | ↑ Buy | 60,500 | $5.90 | $357K | Direct | Aug 31, 2007 (1d) |
| Aug 30, 2007 | PARD | ↑ Buy | 14,469 | $5.90 | $85K | Indirect | Aug 31, 2007 (1d) |
| Aug 29, 2007 | PARD | ↑ Buy | 3,986 | $5.75 | $23K | Direct | Aug 31, 2007 (2d) |
| Aug 29, 2007 | PARD | ↑ Buy | 952 | $5.75 | $5K | Indirect | Aug 31, 2007 (2d) |
| Aug 16, 2007 | PARD | ↑ Buy | 4,168 | $5.49 | $23K | Direct | Aug 16, 2007 (0d) |
| Aug 16, 2007 | PARD | ↑ Buy | 998 | $5.49 | $5K | Indirect | Aug 16, 2007 (0d) |
| Aug 10, 2007 | PARD | ↑ Buy | 11,000 | $5.50 | $61K | Direct | Aug 14, 2007 (4d) |
| Aug 10, 2007 | PARD | ↑ Buy | 2,632 | $5.50 | $14K | Indirect | Aug 14, 2007 (4d) |
| Aug 8, 2007 | VIAP | ↑ Buy | 3,281,151 | $2.43 | $8.0M | Direct | Aug 8, 2007 (0d) |
| Aug 8, 2007 | VIAP | ↑ Buy | 784,831 | $2.43 | $1.9M | Indirect | Aug 8, 2007 (0d) |
| Apr 30, 2007 | PARD | ↑ Buy | 900,000 | $6.33 | $5.7M | Direct | Apr 30, 2007 (0d) |
| Apr 30, 2007 | PARD | ↑ Buy | 215,274 | $6.33 | $1.4M | Indirect | Apr 30, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other XLO insiders
Open-market trades in the last 12 months
About Bay City Capital LLC's insider trades
Bay City Capital LLC is a 10% owner of Xilio Therapeutics (XLO). Since Apr 30, 2007, it has reported 28 open-market purchases worth $55.4M and 12 sales worth $279.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (17 filings), conversions (11 filings), option exercises (8 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.